| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma
|
Samdanci, Emine Turkmen
|
|
|
51 |
4 |
p. 1187-1192
|
artikel
|
| 2 |
Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
|
Akbulut, Sami
|
|
|
51 |
4 |
p. 1107-1113
|
artikel
|
| 3 |
HCC and Tumor Biomarkers: Does One Size Fits All?
|
Ozgor, Dincer
|
|
|
51 |
4 |
p. 1122-1126
|
artikel
|
| 4 |
Introduction to Special Issue on Liver Transplant and HCC at Inonu University, Turkey
|
Yilmaz, Sezai
|
|
|
51 |
4 |
p. 1103
|
artikel
|
| 5 |
Is Macroscopic Portal Vein Tumor Thrombosis of HCC Really an Exclusion for Liver Transplantation?
|
Aydin, Cemalettin
|
|
|
51 |
4 |
p. 1137-1140
|
artikel
|
| 6 |
Living Donor Versus Deceased Donor Liver Transplantation for HCC
|
Doğan, Sait Murat
|
|
|
51 |
4 |
p. 1104-1106
|
artikel
|
| 7 |
Malatya and Other Criteria for Liver Transplantation in Hepatocellular Carcinoma
|
Ince, Volkan
|
|
|
51 |
4 |
p. 1118-1121
|
artikel
|
| 8 |
Management of Recurrent HCC After Liver Transplantation
|
Sarici, Baris
|
|
|
51 |
4 |
p. 1197-1199
|
artikel
|
| 9 |
Microvascular Venous Invasion in Hepatocellular Carcinoma: Why Do Recurrences Occur?
|
Isik, Burak
|
|
|
51 |
4 |
p. 1133-1136
|
artikel
|
| 10 |
Pediatric Hepatocellular Carcinoma
|
Varol, Fatma İlknur
|
|
|
51 |
4 |
p. 1169-1175
|
artikel
|
| 11 |
Portal Vein Thrombosis and Markers of Inflammation in Hepatocellular Carcinoma
|
Carr, B.I.
|
|
|
51 |
4 |
p. 1141-1147
|
artikel
|
| 12 |
Psychosocial Outcomes of Donors Whose Recipients Died After Living Donor Liver Transplantation
|
Ispir, Mukadder
|
|
|
51 |
4 |
p. 1200-1208
|
artikel
|
| 13 |
Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation
|
Kutlu, Ramazan
|
|
|
51 |
4 |
p. 1157-1164
|
artikel
|
| 14 |
Radiomics in Hepatocellular Carcinoma
|
Sagir Kahraman, Aysegul
|
|
|
51 |
4 |
p. 1165-1168
|
artikel
|
| 15 |
The Importance of AFP in Liver Transplantation for HCC
|
Özdemir, Fatih
|
|
|
51 |
4 |
p. 1127-1132
|
artikel
|
| 16 |
The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?
|
Ersan, Veysel
|
|
|
51 |
4 |
p. 1152-1156
|
artikel
|
| 17 |
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth
|
Carr, Brian I.
|
|
|
51 |
4 |
p. 1215-1219
|
artikel
|
| 18 |
Tumor Diameter for Hepatocellular Carcinoma: Why Should Size Matter?
|
Usta, Sertac
|
|
|
51 |
4 |
p. 1114-1117
|
artikel
|
| 19 |
Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint
|
Karadag Soylu, Nese
|
|
|
51 |
4 |
p. 1176-1186
|
artikel
|
| 20 |
What Are the Immune Obstacles to Liver Xenotransplantation Which Is Promising for Patients with Hepatocellular Carcinoma?
|
Yilmaz, Sezai
|
|
|
51 |
4 |
p. 1209-1214
|
artikel
|
| 21 |
What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?
|
Dirican, Abuzer
|
|
|
51 |
4 |
p. 1148-1151
|
artikel
|
| 22 |
Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better?
|
Dikilitas, Mustafa
|
|
|
51 |
4 |
p. 1193-1196
|
artikel
|
Tijdschrift beschrijving